insights_auto
Why is NBIX down ४.४१%?
Dive Deeperchevron_right
NBIX:NASDAQ
Neurocrine Biosciences, Inc
US$ १३५.१३
arrow_downward
-४.४१%(-६.२४) 1D
US$ १३५.५०
arrow_upward
+०.२७% (+०.३७)bedtimeAfter hours
Closed: अक्टोबर १३, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NBIX...
Open
US$ १३९.६०
High
US$ १३९.९२
Low
US$ १३४.८९
Mkt. cap
१३.७४ अरब
Avg. vol.
१३.०० लाख
Volume
०.००
P/E ratio
१९.८१
52-wk high
US$ १८६.१२
52-wk low
US$ १२२.१४
EPS
US$ ६.८२
Beta
०.४०
Shares outstanding
१०.१६ करोड
No. of employees
२ हजार
Open
US$ १३९.६०
High
US$ १३९.९२
Low
US$ १३४.८९
Mkt. cap
१३.७४ अरब
Avg. vol.
१३.०० लाख
Volume
०.००
P/E ratio
१९.८१
52-wk high
US$ १८६.१२
52-wk low
US$ १२२.१४
EPS
US$ ६.८२
Beta
०.४०
Shares outstanding
१०.१६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Barron's
·
७ घण्टा पहिले
This Biopharma Stock Offers Compelling Upside After a Pullback
GuruFocus
·
९ घण्टा पहिले
Is Neurocrine Biosciences Inc (NBIX) a Bargain After 4.4% Drop? GF Value Says Undervalued
Insider Monkey
·
१३ घण्टा पहिले
Axsome Therapeutics (AXSM) vs. Neurocrine Biosciences (NBIX): Is Faster Growth Worth Paying More For?
Zacks
·
१५ घण्टा पहिले
NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?
Profile
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia.
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
About Neurocrine Biosciences, Inc
CEOKevin C. Gorman
Employees२.५ हजार
Founded१९९२
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteneurocrine.com